Skip to content
A new federal research agency would seek solutions for the most challenging diseases, clinical trials would become more diverse, and patients would get new […]
The Cures 2.0 bill: ‘Frankly, patients can’t wait’ Read More »
Australian regulators last week approved a new malaria treatment for children that includes a single-dose medication and promises a new weapon in defeating the
Australia approves use of tafenoquine to treat malaria in children Read More »
The Biotechnology Innovation Organization (BIO) launched a new season of the I am BIO Podcast on March 22, 2022, with an episode for World
I am BIO Podcast: Water Stress: Can We Avert a Looming Crisis? Read More »
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »
Rice University researchers have successfully eradicated advanced-stage ovarian and colorectal cancer in mice in as little as six days by implementing a potentially breakthrough
Implantable ‘drug factories’ eliminate ovarian, colorectal cancer in mice Read More »
Bacterial and fungal infections that follow on the back of SARS-CoV-2 coronavirus have forced doctors to increase the use of antibiotics and antifungal medications,
Squash Superbugs Day of Action to address medical and market challenges of AMR Read More »
Moderna, Inc., a pioneer in the field of messenger RNA (mRNA) medicines and vaccines, has revealed its global public health strategy, which includes four
Moderna targets 15 pathogens in its Global Public Health Strategy Read More »
The U.S. Food and Drug Administration (FDA) on March 4 authorized a shelf-life extension, from six to nine months, for the Janssen COVID-19 vaccine
Janssen COVID-19 vaccine’s shelf-life extended to 9 months Read More »
Autoimmune diseases are a wide range of related illnesses in which a person’s immune system attacks their own tissues. In normal conditions, antibodies are
Autoimmune diseases made more challenging by COVID-19 Read More »
After late-stage clinical human trials showed their protein-based COVID-19 vaccine provided a high level of protection against the disease, the French drugmaker Sanofi and
Sanofi-GSK COVID vaccine moves forward Read More »
